Abstract：Adipocytokines are bioactive substances synthesized and secreted by fat cell. Previous studies have reported an association between weight loss and adipocytokines. However, these studies are inconsistent and they have not clarified the relationship between weight regain and changes in circulating levels of adipocytokines.
Introduction
Overweight and obese individuals are at a greater risk for developing coronary heart disease, type 2 diabetes (T2D), and certain type of cancer compared with their normal-weight counterparts. 1, 2 Weight loss can reduce these risks, but weight maintenance after weight loss is difficult to achieve. [3] [4] [5] Adipose tissue has been considered to be the energy storage tissue, but recent studies have shown that fat cells synthesize and secrete various bioactive substances called adipocytokines, such as leptin, adiponectin, tumor necrosis factor-alpha (TNF-α), free fat acids (FFAs), resistin and angiotensinogen. 6 Most of the studies on adipocyte-derived cytokines have so far focused on the two adipocytokines, adiponectin and leptin, because of their role in the regulation of the metabolic homeostasis. [7] [8] [9] Adiponectin is associated with insulin sensitivity and atherosclerosis. Despite the fact that adiponectin is secreted by the adipose tissue, plasma levels are lower in individuals with obesity, insulin resistance and T2D. [10] [11] [12] Leptin inhibits food intake, stimulates energy expenditure, and regulating immune function. 13 In humans, serum leptin levels are positively correlated with obesity, T2D, hypertension and metabolic syndrome (MetS). 14, 15 Therefore, it is generally considered that obese people are associated with a state of resistance to the effects of leptin. 16, 17 Thus, adiponectin and leptin play an important role on obesity and metabolic disorders. Previous studies have reported an association between weight loss and adipocytokines. 18 However, these studies are inconsistent and they have not clarified the relationship between weight regain and changes of adipocytokines. [19] [20] [21] For example, Ambeba et al. 19 conducted a 24-month weight loss trial and reported that adiponectin increased with weight reduction and decreased with weight regain. On the other hand, Bluher et al. 20 reported continued increase in adiponectin levels with both weight loss and weight regain. They also reported that leptin levels decreased with weight reduction and increased with weight regain. In addition, Crujeiras et al. 21 reported that leptin continued to decrease throughout weight reduction and regain Using the effective intervention program for obesity control developed by our group, a nested randomized intervention trial in human dock examinees was designed to evaluate the multiple metabolic changes and factors involved in weight reduction. Plasma levels of adiponectin, leptin and other biomarkers could be analyzed in relationship with the body weight reduction and changes in fat volume.
SUBJECTS AND METHODS

Study subjects
This study was performed as part of the Saku Control Obesity Program (SCOP). The outline of SCOP has been described previously. 22 The SCOP study protocol initially included 235 Japanese obese subjects (116 men and 119 women) recruited from the database of medical checkup record of Saku Central Hospital Human Dock Center, Nagano, Japan. The study participants had medical checkups since 2000 and were aged 40-64 years old, with a body mass index (BMI: kg/m 2 ) greater than 28.3 (the upper 5 percentile of all examinees).
They were asked to participate in an intervention program for weight control, i.e. Saku Control Obesity have been reported in detail previously. [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] Group A participants were followed for two years after one year intervention, without any period. Clinical and biological parameters were assessed at baseline (0 month), after the end of intervention (12 month) and during the follow-up (24 month) (Fig. 1 ).
As controls, Group B participants received the same intervention as Group A after a delay of one year.
Then they were followed up for one year. They received precise health check-up at 0 month, 12 month, 24 month and 36 month in the same way as Group A participants (Fig. 1) .
The height and weight of the subjects were measured with an automatic scale (Tanita, BF-220, Tokyo, Japan). Their BMI was calculated as weight in kilograms divided by height in meters squared. Waist circumference was measured twice at the umbilicus level while the subject was in a standing position, using a fiberglass measuring tape. The average measurement was used for the analysis. Blood pressure was measured while the subject was in a sitting position using a validated automated blood pressure monitor (ES-H55;
Terumo, Tokyo, Japan). Total fat areas were assessed by a computed tomography scan at the level of the umbilicus, with the subjects in the supine position. The total (TFA), subcutaneous (SFA) and visceral (VFA) fat area were calculated using a commercially available software (Fat Scan; N2 System Corp, Osaka, Japan).
Following an overnight fast, blood samples were collected at the time of each health checkup at the Saku 
Data analysis
Statistical analysis was focused on the effect of intervention by RCT design so that we compared Group A as intervention group and Group B as control group. Furthermore, we analyzed degree of rebound after intervention by combined group A and B data (Group A+B). Data are presented as mean ± SD.
Adipocytokines and CRP were log-transformed to fit normality or linearity assumption for statistical analysis. 
Results
Effect of the intervention by RCT
Baseline characteristics for men and women are displayed in Table 1 . The mean age of the study population was 53.8 years for men and 54.7 years for women. BMI was 30.2±3.1 kg/m 2 for men and 31.0±
3.0 kg/m 2 for women, the waist circumference was 100.0±6.5 cm and 103.2±8.1 cm, and the visceral fat area was 157±48 cm 2 and 129±47 cm 2 (mean±SD) ( Table 1) .
After one year of intervention we observed a 5% body weight reduction (6.1 kg in men and 4.0 kg in women in average) in 51 % participants, 10% reduction in about one fourth participants. The changes of body weight, BMI, fat % in body composition, waist circumference, fat area by CT, and selected biochemical data by group are shown in Table 2 (Table 2) . After the intervention, body weight, BMI, body fat and abdominal fat areas were significantly less than those of controls.
Adipocytokines, lipid, glucose and HbA1c levels of intervention and control groups are shown in Table   3 ( Table 3) . Leptin was significantly lowered than control in both men and women after the intervention. SBP and DBP improved after the intervention. Only in women, TNF-α was significantly increased by intervention (Table 3) .
At baseline health examination revealed the prevalence of dyslipidemia was 64.3% and 40.4% in men and women, high blood pressure was 69.6% and 67.3%, and high blood glucose was 35.7% and 38.5%. The prevalence were improved 19% in both sex in dyslipidemia, 21% and 11% in men and women in high blood pressure, 5% and 30% in high blood glucose, respectively.
Effect of intervention with Group A+B Effect of intervention in fat tissues and adipocytokines
BMI and fat area usually showed good correlations in both males and females (Table 4) . TG correlated with visceral fat and FFA. After the intervention TG showed strong positively correlation with leptin and negatively correlation with adiponectin than before the intervention, except for adiponectin in women.
Adiponectin and leptin inversely correlated only in men. remained. In men TNF-α did not show any association with the above variables.
The change of weight, adiponectin and leptin between before and after the intervention is shown by the quartile of body weight reduction (Fig 2) . Leptin decrease and increase of adiponectin was noticed in upper quartile of body weight reduction by intervention both men and women.
Weight regain during follow-up period
Weight, BMI, waist circumference, HBA 1c , TFA and VFA were significantly increased at the end of follow-up in Group A+B analysis. Both men and women gained about 1.5 kg body weight gain on average.
However, these the end of follow-up values remained significantly lower than those before the intervention (Table 5) .
Leptin value at the end of follow-up showed significantly lower than the end of intervention for men and women. Adiponectin and TNF-α was significantly decreased at the end of follow-up than at the end of intervention both men and women (Table5).
The change of weight and adipocytokine levels for weight regain groups between follow-up periods is
shown by the quartile of body weight regain (Fig. 3) . Leptin was significantly higher in upper quartile of weight regain.
Discussion
In this study, we achieved a 5 percent body weight loss through a one-year lifestyle intervention program using a behavioral approach. In parallel with the weight reduction, many metabolic syndrome-related factors significantly improved. During the intervention, energy source, crops and diary decreased, while the intake of green yellow vegetables increased. 27 Eating speed improved and physical activity also increased compared to the control group. 32 Especially in Group A, women increased their daily physical activity and improved their irregular eating habits during the follow-up period. Eating motivation could be changed through the cognitive-behavior approach.
Following encouragements from trainers, physical activity seemed to be more frequent during the intervention period. This did not last during the follow-up period, while dietary habits seemed to be maintained even after intervention. Altered dietary habit could contribute to the later life. As body weight significantly increased at the end of follow-up examination compared to the weight at the end of the intervention program, fixation of good health habit would be very difficult without decision of individuals.
Decrease and increase of fatty tissue should be a basis of body weight change. Adipose tissue is a major source of energy for the human body. It is also a source of major adipocytokines, adiponectin and leptin 6 . In this study, leptin changed markedly in the process of weight reduction and regain. Adiponectin decreased according to the weight reduction, but not changed between weight regain quartile. Leptin seemed to be highly sensitive to weight changes than adiponectin.
A few studies have explored the relationship between weight change and changes of adipocytokines, but results are inconsistent.
Leptin inhibits food intake, stimulates energy expenditure, and regulating immune function. 13 In humans, serum leptin levels are positively correlated with obesity, T2D, hypertension and metabolic syndrome (MetS). 14, 15 Leptin levels increase in obesity and subcutaneous fat has been a major determinant of circulating leptin levels. The net action of leptin is to inhibit appetite, stimulate thermogenesis, enhance fatty acid oxidation, decrease glucose, and reduce body weight and fat. Our results suggest that leptin change associated with weight reduction and regain, and other effects on metabolic markers.
Weight loss significantly elevates plasma adiponectin levels. We measured HMW-adiponectin in this study. Adiponectin is present in serum as a trimer, hexamer, or high molecular weight form. HMW adiponectin is closely related to coronary artery disease and weight reduction, it affects insulin-sensitizing. 33, 34 Moreover, HMW-adiponectin contributes to the activation of AMP-activated protein kinase, to the suppression of endothelial cell apoptosis, and to cytostatic activity. 35, 36 We propose that early reports describing variable effects of adiponectin should be interpreted with caution, as HMW adiponectin is a more reliable assay reflecting the active form of adiponectin. A reduction in adiponectin has previously been associated with insulin resistance, dyslipidemia, and atherosclerosis in humans.
TNF-α significantly increased by intervention in women even though body weight and fat area decreased.
At the end of follow-up, TNF-α significantly decreased than at the end of intervention both in men and women even though body weight and fat area increased. TNF-α is secreted from not only fat cells but also macrophages. Thus, the changes of TNF-α may be influenced by other factors independently from body weight, obesity or fat cell. It may need further study in the future.
Ambeba et al. 19 conducted the 24 month weight loss trial. They reported that adiponectin increased with weight reduction and decreased with weight regain. These results are similar to our observations. On the other hand, Bluher et al. 20 reported an increase in adiponectin with weight loss. However, there was a continued increase in adiponectin levels with weight regain. There are several differences between Bluher's and our study. First, we conducted separate statistical analysis between sexes, while they analyzed aggregate data.
Furthermore, most of the participants were men (86%). Bluher et al. 20 conducted a 2-year intervention for weight loss, using calorie or carbohydrate diet restrictions.
Our study has several limitations. We could set control group in intervention phase by cross-over design, as Group B participants waited their intervention for one year as a control group of A. However, follow-up period of Group A could not be combined to control group of intervention, because they trailed the effect of intervention. It was impossible to set monthly or yearly wash out period, so this problem should be elaborated in the future epidemiological design of human study. So, there was no control group in follow-up phase.
Secondly, the relationship between dietary and physical activity was not sufficiently connected to the adipocytokine changes. Individual health conditions, different absorption capacities, and different intestinal microbiota could affect the metabolism of individuals and their predisposition to obesity or leanness. 37 Further studies are necessary to better integrate individual holistic variables.
In conclusion, our results suggest that leptin should have broad effects among fat tissues and lipid metabolism. Leptin inversely associated with adiponectin, which in turn was necessary to decrease body weight. In particular, leptin decreased remarkably in the process of weight reduction, and its increase seemed to be related in weight regain. Increase of adiponectin seemed to be induced by the reduction of fat volume. 
